Torii Pharmaceutical : Positive Top line Results of Phase 3 Clinical Study (Comparative Study) of JTE 061 (tapinarof) Cream, Aryl hydrocarbon Receptor (AhR) agonist, in Pediatric Patients with Atopic Dermatitis in Japan
FOR IMMEDIATE RELEASE Tokyo, May 31, 2024 Positive Top-line Results of Phase 3 Clinical Study of JTE-061 Cream, Aryl hydrocarbon Receptor ...